Frank Goebel
NED at SolasCure Ltd, Consultant
Frank Goebel is a hands-on individual with senior executive and deep capital markets as well as structured finance expertise; he has successfully implemented financial transactions in both private and public markets. He has a passion for corporate development (buy & build) and gained first-hand start-up experience from co-founding SolasCure (active in enzymatic debridement). With his clear communication style and solution-oriented approach, he is currently supporting the start-up Plantilizer in developing the equity story, formulating the business plan and building the financial model.
| Experience | ||
| 2018 - ongoing | SolasCure Ltd (UK) | NED |
| 2019 - 2023 | SymbioPharm GmbH | Co-CEO and CFO |
| 2015 - 2018 | BRAIN Group | CFO |
| 2004 - 2014 | Royal Bank of Scotland | Investment Director |
| prior to 2004 | roles in Leveraged Finance, the family’s business, Controlling | |
"In addition to an excellent network and an outstanding operational team, I believe that the spirit and enthusiasm of the people working in and around the HTI is the real strength of the incubator. It's simply fun to interact and exchange ideas - and where people enjoy what they do, there is always progress and the start-ups can benefit from this spirit. For me, soft skills are often more important than professional qualifications when it comes to making a difference in a team. I find the openness of everyone involved and the active support of the start-ups particularly inspiring here."
Frank Goebel